SCHEMBL8958833

SCHEMBL8958833

Cc1ccc(S(=O)(=O)O)cc1CCOC(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP3A4 P08684 2/20 0.34
S1PR3 Q99500 1/20 0.34
GAA P10253 2/20 0.34
TSHR P16473 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
ALOX15 P16050 1/20 0.34
CYP2C19 P33261 1/20 0.34
HPGD P15428 1/20 0.34
DUSP3 P51452 1/20 0.34
PTPN5 P54829 1/20 0.34
PTPN11 Q06124 1/20 0.34
SNCA P37840 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28257564 0.87 S1PR3 (0.36) ALDH1A1CYP3A4S1PR3GAACYP1A2
SCHEMBL9010034 0.84 PTGS2 (0.38) ALDH1A1S1PR3GAASNCAHSD17B10
SCHEMBL872698 0.83 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2S1PR3GAATSHR
SCHEMBL10596213 0.82 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2GAATSHRCYP2C19
SCHEMBL900004 0.81 GAA (0.38) ALDH1A1SMN1; SMN2S1PR3GAATSHR
SCHEMBL29006523 0.79 PTGS2 (0.45) S1PR3SNCA
SCHEMBL8664631 0.79 AOC2 (0.36) ALDH1A1S1PR3SNCACA1CA2
SCHEMBL5861877 0.79 AOC2 (0.36) ALDH1A1S1PR3SNCACA1CA2
SCHEMBL10598218 0.79 SNCA (0.39) ALDH1A1SMN1; SMN2S1PR3GAATSHR
SCHEMBL21358780 0.79 TYR (0.41) ALDH1A1CYP3A4GAACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184613-A1 SULFUR-CONTAINING COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-19 US disclosed
US-5567783-A FLEXIBLE, AMORPHOUS POLYMER; SOLID ELECTROLYTES THE PENN STATE RESEARCH FOUNDATION (US) 1996-10-22 US disclosed
WO-1996027630-A1 IONICALLY CONDUCTIVE POLYPHOSPHAZENES WITH ETHER SIDEGROUPS THE PENN STATE RESEARCH FOUNDATION (US) 1996-09-12 WO disclosed
EP-0524146-A1 Aminosubstituted Piperazinederivatives CIBA-GEIGY AG (CH) 1993-01-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184613-A1 SULFUR-CONTAINING COMPOUND AND USE THEREOF C5, C1S, CYC1 ALDH1A1 1580/4885SMN1; SMN2 883/4885CYP3A4 587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.